Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.86 $3.19 Thursday, 9th May 2024 ATHE stock ended at $2.00. This is 1.96% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 8.63% from a day low at $1.90 to a day high of $2.06.
90 days $1.55 $3.19
52 weeks $1.55 $5.41

Historical Alterity Therapeutics Limited prices

Date Open High Low Close Volume
Apr 04, 2024 $1.84 $1.85 $1.82 $1.84 16 417
Apr 03, 2024 $1.84 $1.89 $1.80 $1.84 17 108
Apr 02, 2024 $1.92 $1.94 $1.81 $1.83 58 743
Apr 01, 2024 $2.05 $2.05 $1.90 $1.95 13 798
Mar 28, 2024 $2.02 $2.12 $1.96 $2.07 67 968
Mar 27, 2024 $1.77 $2.02 $1.77 $2.02 101 620
Mar 26, 2024 $1.75 $1.84 $1.71 $1.80 23 516
Mar 25, 2024 $1.70 $1.76 $1.70 $1.71 19 917
Mar 22, 2024 $1.74 $1.88 $1.73 $1.77 7 257
Mar 21, 2024 $1.71 $1.82 $1.71 $1.77 33 396
Mar 20, 2024 $1.65 $1.77 $1.65 $1.71 20 968
Mar 19, 2024 $1.79 $1.79 $1.66 $1.67 31 226
Mar 18, 2024 $1.87 $1.87 $1.79 $1.80 11 419
Mar 15, 2024 $1.82 $1.88 $1.76 $1.76 22 375
Mar 14, 2024 $1.90 $1.90 $1.80 $1.80 25 441
Mar 13, 2024 $1.76 $1.90 $1.68 $1.87 65 911
Mar 12, 2024 $1.70 $1.73 $1.64 $1.66 25 031
Mar 11, 2024 $1.69 $1.79 $1.67 $1.71 40 508
Mar 08, 2024 $1.76 $1.85 $1.67 $1.71 18 242
Mar 07, 2024 $1.68 $1.73 $1.61 $1.66 38 628
Mar 06, 2024 $1.74 $1.79 $1.68 $1.71 17 296
Mar 05, 2024 $1.99 $1.99 $1.70 $1.75 39 171
Mar 04, 2024 $1.77 $1.78 $1.66 $1.73 6 897
Mar 01, 2024 $1.82 $1.83 $1.73 $1.73 36 813
Feb 29, 2024 $1.91 $1.91 $1.81 $1.87 31 191
Click to get the best stock tips daily for free!

About Alterity Therapeutics Limited

Alterity Therapeutics Limited Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase IIa clinical trial to treat Alzheimer's disease. The company ... ATHE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT